E-LIB Suche - Ergebnisse für: O'Shaughnessy, Joyce

1

heredERA Breast Cancer: a phase III, randomized, open-label..:

Kuemmel, Sherko ; Harper-Wynne, Catherine ; Park, Yeon Hee...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Targeting HER2/HER3 co‐mutations in metastatic breast cance..:

Blas, Page E. ; Rodriguez, Esther San Roman ; Williams, Heather L....
Cancer Reports. 7 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

3

Activity and safety of enobosarm, a novel, oral, selective ..:

Palmieri, Carlo ; Linden, Hannah ; Birrell, Stephen N...
The Lancet Oncology. 25 (2024) 3 - p. 317-325 , 2024

Link: https://doi.org/10.1016/..

4

Impact of dose reductions on adjuvant abemaciclib efficacy ..:

Goetz, Matthew P. ; Cicin, Irfan ; Testa, Laura...
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Dose escalation and expansion cohorts in patients with adva..:

Coombes, R. C. ; Howell, Sacha ; Lord, Simon R....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Clinical effectiveness and safety of olaparib in BRCA-mutat..:

Balmaña, Judith ; Fasching, Peter A. ; Couch, Fergus J....
Breast Cancer Research and Treatment. 204 (2023) 2 - p. 237-248 , 2023

Link: https://doi.org/10.1007/..

7

Incidence and severity of anaphylaxis and hypersensitivity ..:

Swain, Sandra M. ; Tan, Antoinette R. ; Gianni, Luca...
European Journal of Cancer. 178 (2023) - p. 70-81 , 2023

Link: https://doi.org/10.1016/..

8

Association Between Event-Free Survival and Overall Surviva..:

Huang, Min ; Fasching, Peter A ; Haiderali, Amin...
Future Oncology. 20 (2023) 6 - p. 335-348 , 2023

Link: https://doi.org/10.2217/..

9

Matching-adjusted indirect comparison of PFS and OS compari..:

Jhaveri, Komal ; O'Shaughnessy, Joyce ; Fasching, Peter A....
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

10

Pilot clinical trial and phenotypic analysis in chemotherap..:

Lang, Jessica D. ; Nguyen, Tuong Vi V. ; Levin, Maren K....
Biomarker Research. 11 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

11

Anthracycline-containing and taxane-containing chemotherapy..:

Braybrooke, Jeremy ; Bradley, Rosie ; Gray, Richard...
The Lancet. 401 (2023) 10384 - p. 1277-1292 , 2023

Link: https://doi.org/10.1016/..

12

Investigating potential immune mechanisms of trilaciclib ad..:

Tan, Antoinette R. ; O'Shaughnessy, Joyce ; Cao, Subing..
Breast Cancer Research and Treatment. 201 (2023) 2 - p. 307-316 , 2023

Link: https://doi.org/10.1007/..

13

Risk of Recurrence in Patients With HER2+ Early-Stage Breas..:

O'Shaughnessy, Joyce ; Gradishar, William ; O'Regan, Ruth.
Clinical Breast Cancer. 23 (2023) 4 - p. 350-362 , 2023

Link: https://doi.org/10.1016/..

14

Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemot..:

Huang, Min ; A. Fasching, Peter ; Haiderali, Amin...
Advances in Therapy. 40 (2023) 3 - p. 1153-1170 , 2023

Link: https://doi.org/10.1007/..

15

Intrinsic Subtype and Overall Survival of Patients with Adv..:

Prat, Aleix ; Solovieff, Nadia ; André, Fabrice...
Clinical Cancer Research. 30 (2023) 4 - p. 793-802 , 2023

Link: https://doi.org/10.1158/..